Holen Sie sich die Stockscreener-App
2.78
2.51%
-0.01
Schlusskurs vom Vortag:
$2.79
Offen:
$2.76
24-Stunden-Volumen:
25,000
Relative Volume:
0.69
Marktkapitalisierung:
$24.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.74M
KGV:
-1.1076
EPS:
-2.51
Netto-Cashflow:
$-18.90M
1W Leistung:
-2.86%
1M Leistung:
+7.94%
6M Leistung:
+12.86%
1J Leistung:
-13.92%
1-Tages-Spanne:
$2.63
$2.78
1-Wochen-Bereich:
$2.432
$2.98
52-Wochen-Spanne:
$1.87
$4.20
Lisata Therapeutics Inc Stock (LSTA) Company Profile
Firmenname
Lisata Therapeutics Inc
Sektor
Branche
Telefon
908-229-2590
Adresse
110 ALLEN ROAD, BASKING RIDGE
Vergleichen Sie LSTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LSTA
Lisata Therapeutics Inc
|
2.76 | 24.43M | 0 | -20.74M | -18.90M | -2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.33 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
633.37 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.56 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
817.41 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.50 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lisata Therapeutics Inc Aktie (LSTA) Neueste Nachrichten
Why Lisata Therapeutics Inc. stock is rated strong buyMarket Growth Report & Fast Momentum Stock Entry Tips - newser.com
Why Lisata Therapeutics Inc. stock is recommended by analysts2025 Short Interest & Community Consensus Picks - newser.com
Why institutional investors increase stakes in Lisata Therapeutics Inc. (8NE) stockWeekly Volume Report & Community Shared Stock Ideas - newser.com
Key metrics from Lisata Therapeutics Inc.’s quarterly data2025 Historical Comparison & Entry Point Strategy Guides - newser.com
How institutional ownership impacts Lisata Therapeutics Inc. stockWall Street Watch & Real-Time Chart Breakout Alerts - newser.com
Using Bollinger Bands to evaluate Lisata Therapeutics Inc.2025 Momentum Check & Smart Money Movement Tracker - newser.com
Is now a turning point for Lisata Therapeutics Inc.July 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
Can you recover from losses in Lisata Therapeutics Inc.Weekly Stock Report & Short-Term High Return Ideas - newser.com
Custom strategy builders for tracking Lisata Therapeutics Inc.Trade Volume Report & AI Powered Buy/Sell Recommendations - newser.com
Can Lisata Therapeutics Inc. stock weather global recessionJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com
Applying chart zones and confluence areas to Lisata Therapeutics Inc.Weekly Market Report & Safe Capital Growth Tips - newser.com
Is Lisata Therapeutics Inc. stock reversal real or fakeJuly 2025 Market Mood & Long-Term Safe Investment Ideas - newser.com
How sentiment analysis helps forecast Lisata Therapeutics Inc.July 2025 Volume & AI Driven Price Forecasts - newser.com
Will earnings trigger a reversal in Lisata Therapeutics Inc.2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
Why Lisata Therapeutics Inc. (8NE) stock fits value portfoliosJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com
Will Lisata Therapeutics Inc. stock benefit from green energy trendsMarket Trend Report & Real-Time Price Movement Reports - newser.com
Can Lisata Therapeutics Inc. stock continue upward trendPortfolio Return Summary & Accurate Entry/Exit Alerts - newser.com
Candlestick signals on Lisata Therapeutics Inc. stock today2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
Published on: 2025-10-31 04:03:50 - newser.com
How Lisata Therapeutics Inc. stock valuations compare to rivals2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
Can machine learning forecast Lisata Therapeutics Inc. recoveryMarket Rally & Verified Short-Term Plans - newser.com
How buyback programs support Lisata Therapeutics Inc. (8NE) stockJuly 2025 Movers & Smart Swing Trading Techniques - newser.com
Finanzdaten der Lisata Therapeutics Inc-Aktie (LSTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):